$200M Sun/Taro Generic Drug Settlement, Check If You Qualify — In re Generic Pharmaceuticals Pricing Antitrust Litigation, No. 2:16-MD-02724

There’s a share of $200,000,000 waiting for you if you paid for one of nearly 200 generic drugs — antibiotics, blood pressure pills, antidepressants, and more — between May 2009 and December 2019. Sun Pharmaceutical Industries and Taro Pharmaceuticals agreed to pay $200,000,000 to settle antitrust claims over how those drugs were priced. You’ll need to file a claim by November 9, 2026 to get your share.

Quick Facts — Sun/Taro Generic Drug Settlement

Settlement Amount	$200,000,000 (may be reduced by up to $10,000,000 under certain conditions)
Claim Deadline	November 9, 2026
Who Qualifies	Anyone who indirectly purchased, paid for, or was reimbursed for a Named Generic Drug, May 1, 2009 – December 31, 2019, in any U.S. state except Indiana or Ohio, plus D.C., Puerto Rico, and the U.S. Virgin Islands
Estimated Payout	Pro-rata, based on how much you spent — no flat amount
Proof Required (Yes/No)	Yes — proof of purchase for each drug claimed
Settlement Status	Preliminarily approved; Final Fairness Hearing held January 15, 2026; claims process now open
Court & Case Number	U.S. District Court, E.D. Pa. — No. 2:16-MD-02724
Law Alleged	Federal and state antitrust law, consumer protection statutes
Administrator	A.B. Data, Ltd.
Official Claim Site	GenericDrugsEndPayerSettlement.com
Last Updated	July 15, 2026

Who Are Sun and Taro and Why Are They Being Sued Over Generic Drug Prices?

Sun Pharmaceutical Industries and its subsidiary Taro Pharmaceuticals USA are two of more than 50 generic drug manufacturers named in a decade-long price-fixing investigation covering nearly 200 common medications. Plaintiffs say Sun and Taro coordinated with competitors on pricing and market allocation instead of competing on price — the entire reason generics exist in the first place. Sun and Taro deny any wrongdoing, but agreed to pay $200,000,000 rather than keep litigating a case that’s been running since 2016.

What Did Sun and Taro Do to Generic Drug Buyers Between 2009 and 2019?

Plaintiffs allege that Sun, Taro, and dozens of other generic manufacturers violated federal and state antitrust laws by fixing prices, rigging bids, and dividing up customers instead of undercutting each other. On drugs like doxycycline, gabapentin, and warfarin, the companies allegedly agreed on who would raise prices, by how much, and whose territory to stay out of. That’s the opposite of what’s supposed to keep generic prices low.

Sun and Taro are just two names in a much longer list of defendants in this litigation. Settlements with other companies in the same case — Sandoz, Heritage, and Apotex among them — have already resolved on separate timelines.

If you’re checking whether anything else applies to you while you’re here, our running list of claimable class action settlements gets updated as new ones open.

Nobody’s promising you a specific check amount on this one — and anyone who tells you otherwise is guessing.

Who Qualifies for the Sun/Taro Generic Drug Settlement?

Here’s exactly how to know if this case includes you.

• You live in any U.S. state except Indiana or Ohio, or in D.C., Puerto Rico, or the U.S. Virgin Islands
• You indirectly purchased, paid for, or were reimbursed for one or more of nearly 200 Named Generic Drugs — common ones include doxycycline, gabapentin, levothyroxine, and warfarin — sometime between May 1, 2009 and December 31, 2019
• You bought the drug for personal use or reimbursement, not resale, and not directly from Sun, Taro, or another defendant

You don’t qualify if you’re an officer, director, or employee of a defendant company; a federal government entity; most state government entities; a consumer who was covered by Medicaid for that purchase; or a pharmacy benefit manager.

Related article: Liberty Media FP2 Ticket Settlement, Check If You Qualify, Diep v. Liberty Media Corporation, No. 2:23-cv-02124-GMN-NJK

Buyers in Indiana or Ohio — Are You Still Covered?

No, not through this particular settlement. Indiana and Ohio residents are excluded from this class due to differences in those states’ antitrust laws. Every other U.S. state, plus D.C., Puerto Rico, and the U.S. Virgin Islands, is covered.

Not sure if you qualify? A free consultation with a consumer rights attorney can help before the November 9 deadline.

How Much Can Sun/Taro Settlement Class Members Get? Up to $200,000,000 Total

There’s no set dollar amount here. Payment is pro rata, based on how much you spent on Named Generic Drugs during the class period — spend more, get more back; spend less, get less. If fewer than 100% of eligible class members file claims, everyone who does gets a bigger slice of what’s left.

Before any of that gets distributed, the fund covers notice and administration costs (up to $750,000), Class Counsel’s fees (capped at one-third of the fund plus interest), litigation expenses (up to $4,000,000), and service awards for the class representatives (up to $500,000 total). The $200,000,000 headline figure itself could also shrink by up to $10,000,000 under conditions spelled out in the settlement agreement.

You choose how to get paid: ACH direct deposit, Zelle, PayPal, Venmo, or a paper check. Payments over $600 may show up on a 1099 next tax season.

How to File Your Sun/Taro Generic Drug Settlement Claim — Step by Step

1. Go to GenericDrugsEndPayerSettlement.com and open the Consumer Claim Form
2. Check the box confirming you meet the class definition
3. List each Named Generic Drug you bought and how much you paid, using the drug list posted on the site
4. Upload proof of purchase for each drug you list — receipts, pharmacy statements, or account records work
5. Choose your payment method and sign the certification
6. Submit online, or mail the paper form postmarked by November 9, 2026

Takes about 15 minutes if you already have your pharmacy records handy. You have roughly four months left as of this writing — file at GenericDrugsEndPayerSettlement.com.

Can Sun/Taro Class Members Still Opt Out or Object?

What Opting Out Would Have Meant

Opting out would have let you skip this settlement and keep the right to sue Sun and Taro separately over these same price-fixing claims — but you’d have given up any payment from the $200,000,000 fund.

The Window to Object Has Closed

The deadline to request exclusion or file an objection with the court was December 2, 2025, and that window is closed. If you didn’t opt out by then, you’re automatically part of the Settlement Class and eligible to file a claim now.

If you already have a separate individual lawsuit against Sun or Taro over these same claims, talk to your own attorney about how this settlement affects it.

Sun/Taro Generic Drug Settlement — Key Dates, 2026

Milestone	Date
Preliminary Approval	September 23, 2025
Opt-Out / Objection Deadline	December 2, 2025 (passed)
Final Fairness Hearing	January 15, 2026
Claim Filing Deadline	November 9, 2026
Expected Payment Date	TBD — no distribution date has been published yet

Sun/Taro Generic Drug Settlement — Frequently Asked Questions, No. 2:16-MD-02724

Do I need to file a claim for the Sun/Taro generic drug settlement?

 Yes. Unlike some settlements, this one requires a completed claim form with proof of purchase — payment isn’t automatic.

How much will I get from the Sun/Taro settlement?

 There’s no fixed figure. Your payment depends on how much you spent on Named Generic Drugs during the class period and how many other valid claims are filed.

What if I live in Indiana or Ohio?

 You’re excluded from this specific settlement class. Indiana and Ohio residents don’t qualify due to differences in state antitrust law.

Is there a lawsuit against Sun and Taro over generic drug prices?

 Yes — In re Generic Pharmaceuticals Pricing Antitrust Litigation, No. 2:16-MD-02724, in the U.S. District Court for the Eastern District of Pennsylvania. This settlement resolves the claims against Sun and Taro specifically.

Does settling mean Sun and Taro admitted wrongdoing?

 No. Sun and Taro deny the allegations. Settling to end a decade-old antitrust case is standard — it doesn’t mean the underlying claims weren’t real.

Can I still sue Sun and Taro on my own? 

Only if you filed a valid request for exclusion by the December 2, 2025 deadline. That window has passed, so most class members can no longer opt out.

What happened at the January 15 hearing?

 The court considered whether the $200,000,000 settlement, the Plan of Allocation, and Class Counsel’s fee request were fair, reasonable, and adequate.

Who is the settlement administrator and how do I reach them?

 A.B. Data, Ltd. handles the Sun/Taro generic drug settlement claims process. Reach them at 1-877-316-0171 or through GenericDrugsEndPayerSettlement.com.

Sources Used in This Sun/Taro Generic Drug Article

Official Long Form Notice — GenericDrugsEndPayerSettlement.com, dated September 30, 2025: https://www.genericdrugsendpayersettlement.com/assets/Docs/Relating%20to%20the%20Sun%20Taro%20Settlement/Long%20Form%20Notice%20-%20SunTaro%202025-09-30.pdf Official Consumer Claim Form — GenericDrugsEndPayerSettlement.com: https://www.genericdrugsendpayersettlement.com/assets/Docs/2026/EPP%20Consumer%20Claim%20Form.pdf Official Settlement Site — GenericDrugsEndPayerSettlement.com: https://www.genericdrugsendpayersettlement.com/home

This article is for informational purposes only and does not constitute legal advice. Laws vary by state and individual circumstances differ. For advice about your specific situation, consult a qualified attorney.